Search

everythinglearnresearchcommunity

for

Search:↓

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The compound was successfully made and shows potential for treating prostate cancer.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Topical eyedrops may cause eyelash whitening and skin lightening around the eyes.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

Blocking the KATP channel may help treat migraines.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Eosinophilic pustular folliculitis should be considered in teens with persistent skin issues for accurate diagnosis and treatment.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Hair cortisol levels can effectively indicate long-term hormone activity.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

The models accurately predicted urticaria in Ukrainian women but struggled to differentiate between mild and severe cases based on body structure.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.